The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

With an expiration date still more than a year away, here's what the latest details reveal.

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Finding the right ADHD prescription can feel overwhelming at first. With dozens of stimulant and nonstimulant ADHD medications available, many people search for clarity on how these medications work, ...

When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I fit the diagnostic criteria, including sleep problems, time blindness, ...

From February 1, GPs and nurse practitioners will be able to diagnose people with ADHD and prescribe them medication.

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one condition might exacerbate the other. Fluctuating ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...

Despite decades of research, these ADHD myths still affect how people understand attention and behavior.